REFERENCES
- Astegiano M, Sapone N, Demarchi B, et al. Laboratory evaluation of the patient with liver disease. Eur Rev Med Pharmacol Sci 2004;8:3–9.
- Burra P, Masier A. Dynamic tests to study liver function. Eur Rev Med Pharmacol Sci 2004;8:19–21.
- Ilan Y. The assessment of liver function using breath tests. Aliment Pharmacol Ther 2007;26:1293–302.
- Braden B, Lembcke B, Kuker W, Caspary WF. 13C-breath tests: Current state of the art and future directions. Dig Liver Dis 2007;39:795–805.
- Modak AS. Stable istotope breath tests in clinical medicine: A review. J Breath Res 2007;1:R1–R13. doi: 10.1088/1752-7155/1/1/014003
- Armuzzi A, Candelli M, Zocco MA, et al. Breath testing for human liver function assessment. Aliment Pharmacol Ther 2002;16:1977–96.
- Witschi A, Mossi S, Meyer B, et al. Mitochondrial function reflected by the decarboxylation of [13C]ketoisocaproate is impaired in alcoholics. Alcohol Clin Exp Res 1994;18:951–5.
- Mion F, Rousseau M, Brazier JL, Minaire Y. Human hepatic macrovesicular steatosis: A noninvasive study of mitochondrial ketoisocaproic acid decarboxylation. Metabolism 1995;44:699–700.
- Honkoop P, de Man RA, Scholte HR, et al. Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B. Hepatology 1997;26:211–5.
- Gabe SM, Bjarnason I, Tolou-Ghamari Z, et al. The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology 1998;115:67–74.
- Parra D, González A, García-Villarreal L, Martínez JA. Methodological characterization of the 2-keto [1-13C]isocaproate breath test to measure in vivo human mitochondrial function: Application in alcoholic liver disease assessment. Alcohol Clin Exp Res 2003;27: 1293–8.
- Kasicka-Jonderko A, Jonderko K, Kamińska M, et al. 13C-alpha-ketoisocaproic acid breath test revisited – An in-depth reproducibility study advocates an extended breath sampling period. Dig Dis Sci 2007;52:3481–7.
- Opekun AR, Jr., Klein PD, Graham DY.[13C]Aminopyrine breath test detects altered liver metabolism caused by low-dose oral contraceptives. Dig Dis Sci 1995;40:2417–22.
- Van Vlierberghe H, Van Durme F, Verdievel H, et al. Influence of low-dose oral contraceptives, alcohol, and grapefruit on [13C]aminopyrine breath test. Dig Dis Sci 2001;46:133–9.
- Jonderko K, Skałba P, Kasicka-Jonderko A, et al. Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism. Eur J Contracept Reprod Health Care 2013;18:284–92.
- Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19 June – 22 July 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no.2, p. 100) and entered into force on 7 April 1948. Accessed 13 March 2013 from: http://www.who.int/about/definition/en/print.html
- Jonderko K, Kasicka-Jonderko A, Syrkiewicz-Trepiak D, Błońska-Fajfrowska B. Feasibility of a breath test with a substrate of natural 13C-abundance and isotope-selective nondispersive infrared spectrometry. A preliminary study. J Gastroenterol Hepatol 2005;20: 1228–34.
- Kasicka-Jonderko A, Jonderko K, Kamińska M, et al. Breath 13CO2 profiles after intake of three naturally abundant in 13C foods rich in carbohydrates. Ann Acad Med Siles 2006;60:206–12.
- Kasicka-Jonderko A, Nita A, Jonderko K, et al. 13C-methacetin breath test reproducibility study reveals persistent CYP1A2 stimulation on repeat examinations. World J Gastroenterol 2011;17:4979–86.
- Armitage P. Statistical methods in medical research. Oxford: Blackwell Scientific Publications 1978.
- StatSoft, Inc. Electronic statistics textbook. Tulsa, OK: StatSoft 2012. Accessed 13 March 2013 from: http://www.statsoft.com/textbook/
- Khatra BS, Chawla RK, Sewell CW, Rudman D. Distribution of branched-chain alpha-keto acid dehydrogenases in primate tissues. J Clin Invest 1977;59: 558–64.
- Candelli M, Armuzzi A, Miele L, et al. Gender affects 13C-ketoisocaproic acid breath test. Eur Rev Med Pharmacol Sci 2007;11:401–6.
- May ME, Mancusi VJ, Aftring RP, Buse MG. Effects of diabetes on decarboxylation of branched-chain keto acids. Am J Physiol 1980;239:E215–22.
- Lariviere F, Moussalli R, Garrel DR. Increased leucine flux and leucine oxidation during the luteal phase of the menstrual cycle in women. Am J Physiol 1994;267:E422–8.
- Kriengsinyos W, Wykes LJ, Goonewardene LA, et al. Phase of menstrual cycle affects lysine requirement in healthy women. Am J Physiol Endocrinol Metab 2004;287:E489–96.
- Chen JQ, Yager JD, Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta 2005;1746:1–17.
- Chen JQ, Cammarata PR, Baines CP, Yager JD. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta 2009;1793:1540–70.
- Simpkins JW, Yi KD, Yang SH, Dykens JA. Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta 2010;1800:1113–20.
- Chabbert-Buffet N, Chassard D, Ochsenbein E, et al. Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: A double-blind, randomised, dose-finding pilot study. Eur J Contracept Reprod Health Care 2011;16:76–84.
- Sitruk-Ware R, Nath A. Metabolic effects of contraceptive steroids. Rev Endocr Metab Disord 2011;12: 63–75.